Search Medical Condition
Please enter condition
Please choose location
Clear Trial Filters

Body Composition Clinical Trials

A listing of Body Composition medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.


Found (51) clinical trials

Obesity is a growing national health problem that now affects over 35% of Americans and is the leading cause of preventable death. Obesity affects all organ systems and contributes to the cause of a multitude of medical problems such as cardiovascular disease, diabetes and sleep apnea [1]. It is defined ...

Phase N/A

Growth and Body Composition in Preterm Infants

OBJECTIVES GENERAL: Evaluate the growth and body composition of VLBW infants upon reaching the corresponding term gestational age (GA) and weight. SPECIFIC: A) Evaluate the longitudinal growth and body composition of VLBW infants from the first week of life and at the corresponding term GA and weight. B) Relate the ...

Phase N/A

Gut Derived Hormones Body Composition and Metabolism in Prader-Willi Syndrome

Prader-Willi Syndrome (PWS) is the most frequent known genetic disorder of obesity. Hyperphagia is the main barrier to independent living in adults with PWS, and hitherto behavioural restraints and environmental modification are the only effective management measure. The emerging costs for professional care are immense. Thus, there is an urgent ...

Phase N/A

Effect of Rimonabant on Weight Gain and Body Composition in Adults With Prader Willi Syndrome

The purpose of this study is to evaluate the effect of rimonabant, a cannabinoid receptor-1 blocking drug, on the appetite, body weight, body fat and growth hormone level of subjects with Prader-Willi Syndrome (PWS). This will be a double blind placebo controlled clinical trial involving a total of 18 young ...


PR.7 Companion Trial: Effect of Intermittent Versus Continuous Androgen Suppression on Bone Loss and Body Composition

Primary Objectives: 1. To compare CAS and IAS with respect to bone mineral density (BMD): We will determine whether the bone loss associated with long term CAS can be reduced by IAS by evaluation of: 1. BMD, 2. biochemical markers of bone formation/resorption, 3. skeletal relevant events (SRE) (defined as ...


Pulmonary Hypertension: Efficacy of a 3 Week Inpatient Rehabilitation on Physical Condition Body Composition and Health Related Quality of Life

Pulmonary hypertension (PH) impairs physical condition (PC), body composition (BC) and health-related quality of life (HRQOL). Specific pharmacological treatment and - in selected patients, refractory to agents - lung or combined heart and lung transplantation can improve physical functioning and long term survival. Initial trials with limited numbers of patients ...

Phase N/A

The Effect of Neprilysin (LCZ696) on Exercise Tolerance in Patients With Heart Failure

Heart failure (HF) with reduced ventricular ejection fraction is a disease that affects around 5.7 million people in the United States, with a mortality rate of approximately 50% within 5 years. HF is characterized by an exacerbation of the renin-angiotensin-aldosterone system (RAAS), which leads to an increase in sympathetic nerve ...


Body Composition and Adipose Tissue in HIV

HIV lipodystrophy is increasingly recognized as a common and clinically significant long-term sequelae of HIV treatment. In the HIV lipodystrophy lipohypertrophy phenotype, visceral adipose tissue (VAT) is increased and this is associated with reduced growth hormone (GH) secretion. Mounting evidence also links this phenotype with dyslipidemia, insulin resistance, subclinical atherosclerosis ...


Development and Validation of Multi-nuclear Magnetic Resonance Imaging and Spectroscopy for Whole Body Human Applications

The purpose of this study is to develop and refine the techniques for using magnetic resonance imaging and magnetic resonance spectroscopy to understand the composition and function of the human body

Phase N/A

Evolution of Adipokines and Body Composition in Rheumatoid Arthritis Patients Receiving Tocilizumab Therapy

Rheumatoid arthritis (RA) is a chronic inflammatory disease associated with cardiovascular morbidity. Tocilizumab (TCZ), a monoclonal antibody against the interleukin-6 receptor is an effective new biotherapy for the treatment of RA. This treatment is associated with increased LDL and HDL-cholesterol lipid parameters. Adipokines are adipose tissue-specific secreted molecules, which have ...